Chiltern India's Network of Investigators in Select Therapeutic Areas (Cinista), is a forum consisting of 30 select eminent medical and clinical research experts in 11 therapeutic areas
Clinical research organisation Chiltern India has developed an innovative and unique way to build on its growing relationships with some of the country's best investigators.
Chiltern India's Network of Investigators in Select Therapeutic Areas (Cinista), is a forum consisting of 30 select eminent medical and clinical research experts in 11 therapeutic areas and is spread over 15 cities.
Its members are the key opinion leaders in their respective therapeutic areas in India and have a rich experience of undertaking global multi-centric trials.
All of them are well trained in GCP and a number are ACRP-certified investigators.
These opinion leaders will represent the preferred primary contact for Chiltern India and will support the company in undertaking rapid feasibility reviews for potential studies.
They will function as principal investigators or coordinating investigators and provide trial sponsors with their views and advice for areas such as trial design, study conduct and interim analysis.
These members will also present the protocol if required to the regulatory authorities in India on behalf of the sponsors and clarify any medical related queries.
"We are delighted to announce the setting up of this network," commented Umakanta Sahoo, general manager of Chiltern India.
"With the support of Cinista's members, Chiltern will enable a mutually beneficial relationship to be built between biopharmaceutical companies and the growing Indian clinical research fraternity.
"In line with the expansion of Chiltern India the membership of Cinista will grow to accommodate other therapeutic areas and cities".
The 11 therapeutic areas covered by Cinista are respiratory, endocrinology, dermatology, neurology, haematology, oncology, rheumatology, nephrology, surgery, paediatrics, and pharmacology.
